J and J Snack Foods Newswire

Comprehensive Real-Time News Feed for J and J Snack Foods.

Results 1 - 20 of 536 in J and J Snack Foods

  1. Dirty Bird Daily: Latest Atlanta Falcons NewsRead the original story w/Photo

    16 hrs ago | BlogginDirty

    Happy Saturday morning, Falcons fans. It's finally the weekend, and we have plenty of updates to bring you from the world of the Atlanta Falcons.

    Comment?

  2. Lack of talent will hamper continuous manufacturing adoption, says MIT ProfRead the original story w/Photo

    Wednesday May 13 | In-PharmaTechnologist.com

    A lack of scientific talent will hold pharma back from adopting continuous manufacturing despite the imminent opening of regulatory pathways, says an MIT Professor. Continuous manufacturing in the pharma industry "is the future," the US FDA's CDER Director Janet Woodcock said earlier this month as she pushed for legislation and grants to help encourage drugmakers to make the switch from batch production.

    Comment?

  3. Just In Time For The Holiday: J&J, Sony, VW Launch Media ReviewsRead the original story w/Photo

    Friday | MediaPost

    Just as Adlanders were packing up and heading off to a long and relaxing Memorial Day weekend, all hell broke loose on the media agency review front. Johnson & Johnson has called for a media review, although there were conflicting accounts as to its scope -- with some sources indicating that it's global, while others said it is focused on media assignments outside of the U.S. Those reviews follow closely on the heels of three other major media reviews called earlier in the week - 21st Century Fox , BMW and BASF.

    Comment?

  4. Share on LinkedInRead the original story w/Photo

    Friday | MediaPost

    Just as Adlanders were packing up and heading off to a nice long and relaxing Memorial Day weekend, all hell broke loose on the media agency review front. Johnson & Johnson has called for a media review, although there were conflicting accounts as to its scope -- with some sources indicating that it's global, while others said it is focused on media assignments outside of the U.S. Meanwhile, Sony Pictures and Volkswagen have launched global media pitches.

    Comment?

  5. J&J Puts $2.6 Billion Global Media Account in ReviewRead the original story w/Photo

    Friday | Advertising Age

    Add one more to the list of giant marketers launching media reviews: Johnson & Johnson has placed its $2.6 billion global media buying and planning account into review, the company confirmed. J&J reported $2.6 billion in advertising spending in its 2014 annual report.

    Comment?

  6. Johnson & Johnson Pegs Its Long-Term Growth Potential On PreventionRead the original story w/Photo

    Wednesday May 20 | Forbes.com

    I am a science journalist and author who specializes in covering healthcare, pharmaceuticals and biotechnology. I am the author of Heal: The Vital Role of Dogs in the Search for Cancer Cures and Selling the Fountain of Youth .

    Comment?

  7. Latitude 360 Partners With Julio Jones, Wide Receiver for the Atlanta FalconsRead the original story

    Thursday | Digital Game Developer

    "Mr. Jones shares our enthusiasm for our proven concept in dining and entertainment. These new locations will join Indianapolis , Pittsburgh and Jacksonville as well as planned locations in is a wide receiver for the Atlanta Falcons of the National Football League .

    Comment?

  8. Can This J&J Drug Reshape Schizophrenia Treatment?Read the original story w/Photo

    Thursday May 21 | Investopedia

    Keeping schizophrenia patients on their medication is one of the biggest challenges facing mental health doctors. That means there is a significant unmet need for treatment options that offer longer-lasting medications that can be taken less frequently and boost patient adherence rates, such as Johnson & Johnson 's new formulation of its top-selling Invega Sustenna.

    Comment?

  9. J&J to submit at least 10 new drugs for approval by 2019Read the original story

    Wednesday May 20 | WNFL-AM Green Bay

    U.S. healthcare conglomerate Johnson & Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of daratumumab for the blood cancer multiple myeloma in the United States and Europe this year based on mid-stage clinical data.

    Comment?

  10. J&J Invests in Alzheimer's, Cancer as Competitive Threats EmergeRead the original story

    Wednesday May 20 | The Washington Post

    Johnson & Johnson is investing in a collection of experimental drugs with blockbuster potential, treating widespread illnesses like blood cancer and Alzheimer's disease, to help rise above looming competitive threats to its pharmaceutical business. The world's biggest maker of health products said Wednesday it plans to seek regulatory approval for more than 10 new drugs by 2019 with potential annual sales of more than $1 billion apiece.

    Comment?

  11. Orexigen CEO Pledged To Keep Data Secret, But Not From HimselfRead the original story w/Photo

    Wednesday May 20 | Forbes.com

    I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today.

    Comment?

  12. Healthy foods: Coming soon to a theater near you?Read the original story w/Photo

    Tuesday May 19 | Salt Lake Tribune

    The Salt Lake Tribune) Snacks that could be coming soon to a movie theater near you, from left: Mrs. May's blueberry almond-flavored Mini Crunch, Cracker Jack'D PB & Chocolate-flavored Hearty Mix, Brookside Acai & Blueberry-flavored Dark Chocolate and Dole orange-flavored Fruit Snacks. The Salt Lake Tribune) Snacks that could be coming soon to a movie theater near you, from left: Mrs. May's blueberry almond-flavored Mini Crunch, Cracker Jack'D PB & Chocolate-flavored Hearty Mix, Brookside Acai & Blueberry-flavored Dark Chocolate and Dole orange-flavored Fruit Snacks.

    Comment?

  13. Like Big Dividends? 6 Steady Payers You Can Rely OnRead the original story w/Photo

    Tuesday May 19 | Investor's Business Daily

    Here are six of the most reliable dividend payers whose yields also beat the market. IBD's Dividend Stability Factor shows how stable a company's dividend history is over a five-year period.

    Comment?

  14. Us Fda investigates Az, J&J and B-I's type 2 diabetes drugs after adverse eventsRead the original story w/Photo

    Monday May 18 | In-PharmaTechnologist.com

    Diabetes drugs made by J&J, AstraZeneca and Boehringer-Ingelheim are being investigated by the US FDA after 20 cases of acidosis resulting in hospitalisation were recorded. Between May 2013 and June 2014, the US Food and Drug Administration recorded 20 cases of acidosis resulting in emergency room visits or hospitalisation in patients who had taken sodium-glucose cotransporter-2 inhibitors, used to help control blood sugar in adults with type 2 diabetes.

    Comment?

  15. West Pharmaceutical: Diverse Product Portfolio And Growth OptionalityRead the original story w/Photo

    Tuesday May 12 | Seeking Alpha

    The company is experiencing temporary weakness due to currency fluctuations - every $0.01 decrease in the value in a vs the $ is about ~ annual EPS. We believe the stock is near its intrinsic value to using an APV method, but growth catalysts on the upside and under-coverage by Wall Street provide optionality for investors.

    Comment?

  16. 'WWE Raw': Daniel Bryan Goes HomeRead the original story w/Photo

    Tuesday May 12 | RollingStone

    Hello ladies and gents, and welcome to the final recap before Payback , or as I like to call it, Extreme Rules Part 1 1/2 . Last night's show emanated from Cincinnati, Ohio, commonly known as that major American city we always forget is perilously close to Kentucky.

    Comment?

  17. WWE Raw Review: Daniel Bryan relinquishes IC titleRead the original story w/Photo

    Tuesday May 12 | Alabama Live

    Instead, last night's Raw will be remembered for Daniel Bryan's injury issues again forcing WWE writers to alter long-term storylines. Bryan, who had to vacate the heavyweight title last year due to a neck injury, announced to the Cincinnati crowd that he is relinquishing the intercontinental belt due to to lingering issues with his recovery.

    Comment?

  18. Model N (MODN) CEO Zack Rinat on Q2 2015 Results - Earnings Call TranscriptRead the original story w/Photo

    Monday May 11 | Seeking Alpha

    Greetings and welcome to the Model N Second Quarter Fiscal 2015 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

    Comment?

  19. What Does A $30 Trillion Customer Service Experience Look Like?Read the original story w/Photo

    Monday May 11 | Forbes.com

    I'm Chairman, North America of Landor Associates, a brand consulting and design firm that specializes in creating agile brands that thrive in today's disruptive, changing market. I work with some of the most powerful brands in the world, and oversee Landor's new business efforts in North America.

    Comment?

  20. Bioethics expert guides pharma firm on who gets its experimental drugsRead the original story w/Photo

    Monday May 11 | NatureNews

    Early last year seven-year-old Josh Hardy lay terminally ill at a hospital in Memphis, Tenn. He was combating a life-threatening adenovirus infection and his physicians had run out of options.

    Comment?